| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Xavier Boland, Luiz Dratc. First Use of Clozapine Point of Care Testing in Acute Inpatient Psychiatry: Preliminary Report. Journal of psychiatric practice. vol 28. issue 1. 2022-01-06. PMID:34989347. |
clozapine is the antipsychotic of choice in treatment-resistant schizophrenia. |
2022-01-06 |
2023-08-13 |
Not clear |
| James L Laws, Esther Kim, Rebecca Hung, JoAnn Lindenfeld, Richa Gupt. Chest Pain in a Psychiatric Patient Due to Clozapine-Induced Myopericarditis. Case reports in cardiology. vol 2021. 2022-01-03. PMID:34976414. |
drug-induced myocarditis is a rare, but underrecognized complication of clozapine therapy for schizophrenia. |
2022-01-03 |
2023-08-13 |
Not clear |
| Mizuki Hino, Takeshi Kondo, Yasuto Kunii, Junya Matsumoto, Akira Wada, Shin-Ichi Niwa, Mitsutoshi Setou, Hirooki Yab. Tubulin/microtubules as novel clozapine targets. Neuropsychopharmacology reports. 2021-12-29. PMID:34964309. |
clozapine is currently the only effective drug for treatment-resistant schizophrenia; nonetheless, its pharmacological mechanism remains unclear, and its administration is limited because of severe adverse effects. |
2021-12-29 |
2023-08-13 |
Not clear |
| Yasin Bez, Sindhura Kompella, Felicia Gallucci, Adam Awerbuch, Barbara J Coffe. Clinical Use of Clozapine Serum Level and Management of Adverse Effects in an Adolescent with Difficult to Treat Schizophrenia. Journal of child and adolescent psychopharmacology. vol 31. issue 10. 2021-12-27. PMID:34958240. |
clinical use of clozapine serum level and management of adverse effects in an adolescent with difficult to treat schizophrenia. |
2021-12-27 |
2023-08-13 |
Not clear |
| Sandeep Grover, Swapnajeet Sahoo, Aseem Mehr. Safe use of Clozapine in a patient with treatment resistant schizophrenia with co-morbid Dilated cardiomyopathy: A case report. Asian journal of psychiatry. vol 68. 2021-12-25. PMID:34953217. |
safe use of clozapine in a patient with treatment resistant schizophrenia with co-morbid dilated cardiomyopathy: a case report. |
2021-12-25 |
2023-08-13 |
Not clear |
| Samantha Christine Sernoskie, Alexandra R Lobach, Ryuji Kato, Alison Jee, J Kyle Weston, Jack Uetrech. Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis. Toxicological sciences : an official journal of the Society of Toxicology. 2021-12-22. PMID:34935985. |
although clozapine is a highly efficacious schizophrenia treatment, it is under-prescribed due to the risk of idiosyncratic drug-induced agranulocytosis (idiag). |
2021-12-22 |
2023-08-13 |
human |
| Robert Løvsletten Smith, Birgit M Wollmann, Lennart Kyllesø, Thu Thuy Anh Tran, Marit Tveito, Espen Molde. Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia. Journal of clinical psychopharmacology. vol 42. issue 1. 2021-12-20. PMID:34928560. |
effect of valproic acid on the metabolic spectrum of clozapine in patients with schizophrenia. |
2021-12-20 |
2023-08-13 |
Not clear |
| Maité A Cintrón Pastrana, Erick Quintana Avile. Treatment of Refractory Schizophrenia With Clozapine in a Patient With Wolff-Parkinson-White Syndrome. Journal of clinical psychopharmacology. vol 42. issue 1. 2021-12-20. PMID:34928564. |
treatment of refractory schizophrenia with clozapine in a patient with wolff-parkinson-white syndrome. |
2021-12-20 |
2023-08-13 |
Not clear |
| Theja Bhamidipati, Krishna Divadeena. Management of Clozapine Titration in the Setting of Cardiac Comorbidities. Cureus. vol 13. issue 11. 2021-12-11. PMID:34881120. |
treatment-resistant schizophrenia is commonly treated by the initiation of clozapine therapy. |
2021-12-11 |
2023-08-13 |
Not clear |
| Jisha M Lucca, Fatima M Al-Turaifi, Al-Mubayedh Safyah, Feras A Hamad Al-Awa. A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario. Psychopharmacology bulletin. vol 51. issue 4. 2021-12-11. PMID:34887598. |
clozapine is considered as effective medication for treatment resistant schizophrenia. |
2021-12-11 |
2023-08-13 |
Not clear |
| M B Deepak, Kalra Deeksha, Rajhans Pallavi, Choudhary Hemant, Bajaj Nidhisha, Deep Rama. Clozapine Induced Hypertension and its Association with Autonomic Dysfunction. Psychopharmacology bulletin. vol 51. issue 4. 2021-12-11. PMID:34887604. |
clozapine is a second generation antipsychotic agent which is drug of choice for treatment resistant schizophrenia. |
2021-12-11 |
2023-08-13 |
Not clear |
| Sandeep Grover, Kripa Shanker Kasudhan, Naveen Murali, Amol N Patil, Smita Pattanaik, Subho Chakrabarti, Ajit Avasth. Pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: Preliminary exploration of future too near. Asian journal of psychiatry. vol 67. 2021-12-10. PMID:34844176. |
pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: preliminary exploration of future too near. |
2021-12-10 |
2023-08-13 |
Not clear |
| Sandeep Grover, Kripa Shanker Kasudhan, Naveen Murali, Amol N Patil, Smita Pattanaik, Subho Chakrabarti, Ajit Avasth. Pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: Preliminary exploration of future too near. Asian journal of psychiatry. vol 67. 2021-12-10. PMID:34844176. |
to study the association of clozapine pharmacometabolomics and clozapine response in asian patients with treatment-resistant schizophrenia (trs). |
2021-12-10 |
2023-08-13 |
Not clear |
| Kotaro Hatta, Shigemasa Katayama, Takuya Ishizuka, Yasuhiko Sudo, Mitsuru Nakamura, Hana Hasegawa, Atsushi Imai, Fumiyoshi Morikawa, Tatsuhiro Shimada, Fuminari Misawa, Shigeru Ozaki, Kiyoshi Fujita, Haruo Watanabe, Hiroyuki Nakamura, Naoya Sugiyam. Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study. Asian journal of psychiatry. vol 67. 2021-12-10. PMID:34875558. |
to compare the real-world effectiveness of antipsychotic treatments focusing on long-acting injectable antipsychotic medications (lais) and antipsychotic polytherapies except polytherapy involving clozapine (apec) for patients with schizophrenia. |
2021-12-10 |
2023-08-13 |
Not clear |
| Jari-Pekka Klemettilä, Anssi Solismaa, Niko Seppälä, Mari Hämäläinen, Eeva Moilanen, Esa Leinonen, Olli Kampma. Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine. Psychiatry research. vol 306. 2021-12-06. PMID:34610543. |
the aim of the present study was to test the possible role of serum glp-1 and visfatin level alterations as markers of weight gain in association with metabolic and inflammatory markers in 190 patients (109 male, 81 female) with schizophrenia on clozapine treatment. |
2021-12-06 |
2023-08-13 |
Not clear |
| Jari-Pekka Klemettilä, Anssi Solismaa, Niko Seppälä, Mari Hämäläinen, Eeva Moilanen, Esa Leinonen, Olli Kampma. Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine. Psychiatry research. vol 306. 2021-12-06. PMID:34610543. |
serum glp-1 level seems to be a marker of metabolic risk factors among men with schizophrenia on clozapine treatment. |
2021-12-06 |
2023-08-13 |
Not clear |
| Mehrnoosh Azimi Sanavi, Hamed Ghazvini, Mehryar Zargari, Hossein Ghalehnoei, Zahra Hosseini-Kha. Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia. Neuroscience letters. 2021-12-06. PMID:34801642. |
effects of clozapine and risperidone antipsychotic drugs on the expression of cacna1c and behavioral changes in rat 'ketamine model of schizophrenia. |
2021-12-06 |
2023-08-13 |
rat |
| Bo Tao, Yuan Xiao, Hengyi Cao, Wenjing Zhang, Chengmin Yang, Rebekka Lencer, Qiyong Gong, Su Lu. Characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated. BMC psychiatry. vol 21. issue 1. 2021-12-03. PMID:34715831. |
characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated. |
2021-12-03 |
2023-08-13 |
Not clear |
| Norio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, Shinichiro Ochi, Shusuke Numata, Hikaru Hori, Akitoyo Hishimoto, Toshiaki Onitsuka, Kazutaka Ohi, Naoki Hashimoto, Tatsuya Nagasawa, Yoshikazu Takaesu, Takahiko Inagaki, Hiromi Tagata, Takashi Tsuboi, Chika Kubota, Ryuji Furihata, Jun-Ichi Iga, Hitoshi Iida, Kenichiro Miura, Junya Matsumoto, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Kazutaka Shimoda, Ryota Hashimot. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Neuropsychopharmacology reports. 2021-12-02. PMID:34854260. |
association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. |
2021-12-02 |
2023-08-13 |
Not clear |
| Norio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, Shinichiro Ochi, Shusuke Numata, Hikaru Hori, Akitoyo Hishimoto, Toshiaki Onitsuka, Kazutaka Ohi, Naoki Hashimoto, Tatsuya Nagasawa, Yoshikazu Takaesu, Takahiko Inagaki, Hiromi Tagata, Takashi Tsuboi, Chika Kubota, Ryuji Furihata, Jun-Ichi Iga, Hitoshi Iida, Kenichiro Miura, Junya Matsumoto, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Kazutaka Shimoda, Ryota Hashimot. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Neuropsychopharmacology reports. 2021-12-02. PMID:34854260. |
the decision to initiate clozapine treatment should be made on an individual basis and may be closely related to the early detection of treatment-resistant schizophrenia (trs), although there is evidence that the early use of clozapine results in a better response to treatment. |
2021-12-02 |
2023-08-13 |
Not clear |